• 1
    Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010: 235-241.
  • 2
    Yusuf S, Hawken S, Ounpuu S et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-952.
  • 3
    McGee DL. Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies. Ann Epidemiol 2005; 15: 87-97.
  • 4
    Canoy D, Boekholdt SM, Wareham N et al. Body fat distribution and risk of coronary heart disease in men and women in the European Prospective Investigation Into Cancer and Nutrition in Norfolk cohort: a population-based prospective study. Circulation 2007; 116: 2933-2943.
  • 5
    Balkau B, Deanfield JE, Després JP et al. International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation 2007; 116: 1942-1951.
  • 6
    Goodpaster BH, Krishnaswami S, Resnick H et al. Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Diabetes Care 2003; 26: 372-379.
  • 7
    Brook RD, Bard RL, Rubenfire M, Ridker PM, Rajagopalan S. Usefulness of visceral obesity (waist/hip ratio) in predicting vascular endothelial function in healthy overweight adults. Am J Cardiol 2001; 88: 1264-1269.
  • 8
    Parikh NI, Keyes MJ, Larson MG et al. Visceral and subcutaneous adiposity and brachial artery vasodilator function. Obesity (Silver Spring) 2009; 17: 2054-2059.
  • 9
    Hamburg NM, Keyes MJ, Larson MG et al. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation 2008; 117: 2467-2474.
  • 10
    Mitchell GF, Parise H, Vita JA et al. Local shear stress and brachial artery flow-mediated dilation: the Framingham Heart Study. Hypertension 2004; 44: 134-139.
  • 11
    Yusuf S, Hawken S, Ounpuu S et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005; 366: 1640-1649.
  • 12
    Cepeda-Valery B, Pressman GS, Figueredo VM, Romero-Corral A. Impact of obesity on total and cardiovascular mortality-fat or fiction? Nat Rev Cardiol 2011; 8: 233-237.
  • 13
    Browning LM, Hsieh SD, Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0·5 could be a suitable global boundary value. Nutr Res Rev 2010; 23: 247-269.
  • 14
    Welborn TA, Dhaliwal SS, Bennett SA. Waist-hip ratio is the dominant risk factor predicting cardiovascular death in Australia. Med J Aust 2003; 179: 580-585.
  • 15
    Welborn TA, Dhaliwal SS. Preferred clinical measures of central obesity for predicting mortality. Eur J Clin Nutr 2007; 61: 1373-1379.
  • 16
    Anderson TJ, Charbonneau F, Title LM et al. Microvascular function predicts cardiovascular events in primary prevention: long-term results from the Firefighters and Their Endothelium (FATE) study. Circulation 2011; 123: 163-169.
  • 17
    Anderson TJ, Roberts AC, Hildebrand K et al. The fate of endothelial function testing: rationale and design of the Firefighters And Their Endothelium (FATE) study. Can J Cardiol 2003; 19: 61-66.
  • 18
    Bergman RN, Stefanovski D, Buchanan TA et al. A better index of body adiposity. Obesity (Silver Spring) 2011; 19: 1083-1089.
  • 19
    Yan RT, Yan AT, Anderson TJ et al. The differential association between various anthropometric indices of obesity and subclinical atherosclerosis. Atherosclerosis 2009; 207: 232-238.
  • 20
    Yan RT, Anderson TJ, Charbonneau F et al. Relationship between carotid artery intima-media thickness and brachial artery flow-mediated dilation in middle-aged healthy men. J Am Coll Cardiol 2005; 45: 1980-1986.
  • 21
    Corretti MC, Anderson TJ, Benjamin EJ et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39: 257-265.
  • 22
    Meredith IT, Currie KE, Anderson TJ et al. Post-ischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide. Am J Physiol 1996; 270: H1435-H1440.
  • 23
    Philpott A, Anderson TJ. Reactive hyperemia and cardiovascular risk. Arterioscler Thromb Vasc Biol 2007; 27: 2065-2067.
  • 24
    Philpott AC, Lonn E, Title LM et al. Comparison of new measures of vascular function to flow mediated dilatation as a measure of cardiovascular risk factors. Am J Cardiol 2009; 103: 1610-1615.
  • 25
    Alberti KG, Eckel RH, Grundy SM et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-1645.
  • 26
    Organization WHO. Waist circumference and waist-hip ratio: report of a WHO expert consultation, Geneva, 8-11 December 2008.
  • 27
    Després JP, Lemieux I, Bergeron J et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008; 28: 1039-1049.
  • 28
    Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S. Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol 2005; 288: H2031-H2041.
  • 29
    Arita Y, Kihara S, Ouchi N et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 79-83.
  • 30
    Shimabukuro M, Higa N, Asahi T et al. Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J Clin Endocrinol Metab 2003; 88: 3236-3240.
  • 31
    Shankar SS, Steinberg HO. Obesity and endothelial dysfunction. Semin Vasc Med 2005; 5: 56-64.
  • 32
    Steinberg HO, Paradisi G, Hook G et al. Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes 2000; 49: 1231-1238.
  • 33
    Lundman P, Tornvall P, Nilsson L, Pernow J. A triglyceride-rich fat emulsion and free fatty acids but not very low density lipoproteins impair endothelium-dependent vasorelaxation. Atherosclerosis 2001; 159: 35-41.
  • 34
    Couloubaly S, Deloménie C, Rousseau D et al. Fatty acid incorporation in endothelial cells and effects on endothelial nitric oxide synthase. Eur J Clin Invest 2007; 37: 692-699.
  • 35
    de Jongh RT, Serné EH, IJzerman RG, de Vries G, Stehouwer CD. Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance. Circulation 2004; 109: 2529-2535.
  • 36
    Al Suwaidi J, Higano ST, Holmes DR Jr, Lennon R, Lerman A. Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries. J Am Coll Cardiol 2001; 37: 1523-1528.
  • 37
    Worthley MI, Curtis MJ, Goodhart DM, Anderson TJ. Obesity is associated with impaired human coronary endothelial function. Obes Res Clin Pract 2009; 3: 9-15.
  • 38
    Yeboah J, Crouse JR, Hsu FC, Burke GL, Herrington DM. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation 2007; 115: 2390-2397.
  • 39
    Hu FB. Obesity Epidemiology, 1st edn. Oxford University Press: Oxford, 2008.
  • 40
    Burke GL, Bertoni AG, Shea S et al. The impact of obesity on cardiovascular disease risk factors and subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis. Arch Intern Med 2008; 168: 928-935.
  • 41
    Title LM, Lonn E, Charbonneau F et al. Relationship between brachial artery flow-mediated dilatation, hyperemic shear stress, and the metabolic syndrome. Vasc Med 2008; 13: 263-270.